Lidocaine Gel (Toyo Pharmaceutical)

N/A

Report date: 2025/07/21 10:30:02

Base Information

Drug NameLidocaine Gel (Toyo Pharmaceutical)
Drug Alias NameTH-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesToyo Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuralgia, Postherpetic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A